Based on these data and in view of our findings, we propose a signalosome composed of membrane CD146, VEGFR2 and integrin αvβ3 on glioblastoma cells that mediates sCD146 effects and regulates the MAPK/FAK signaling axis which will, in turn, control cell proliferation, migration and invasion. The gene discussed is MCAM; the disease is glioblastoma.